Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases
Lopukhova, N.L.
Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 146-152
2007
ISSN/ISBN: 1682-8658 PMID: 18409502 Document Number: 607983
Document emailed within 1 workday
Related Documents
Dong, Y.; Zhang, H.-f.; Chen, H.; Li, J.; Yang, X.-j.; Zhu, S.-s.; Cheng, Y. 2008: Level of the cytokine secreted by periferal blood mononuclear cells in patients with chronic hepatitis C before antiviral therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 22(5): 364-366Baranova, I.P.; Zykova, O.A.; Krasnova, L.I.; Romantsov, M.G.; Nikol'skaia, M.V.; Aftaeva, L.N. 2013: Efficiency of remaxol in preventing unwanted side effects of the antiviral therapy in patients with chronic hepatitis C Eksperimental'naia i Klinicheskaia Farmakologiia 76(11): 44-46
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Xu, D.-Z.; Xie, Y.; Li, Z.-Q. 2005: Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(4): 550-553
Gwak, G-Youn.; Kim, T.Hun.; Yu, S.Jong.; Yoon, J-Hwan.; Yong, J.Jung.; Park, S.Cheol.; Lee, H-Suk. 2007: Lack of association between serum leptin levels and hepatic steatosis, fibrosis or response to antiviral therapy in Korean chronic hepatitis C patients Hepato-Gastroenterology 54(75): 844-848
Geller, L.I. 1990: Antiviral preparations in the therapy of chronic viral hepatitis Terapevticheskii Arkhiv 62(11): 15-19
Zhdanov, K.V.; Gusev, D.A.; Kozlov, K.V.; Shishkin, M.K.; Sukachev, V.S.; Shakhmanov, D.M.; Zhabrov, S.S. 2015: Effectiveness and safety of antiviral therapy of military personnel suffering from chronic hepatitis C Voenno-Meditsinskii Zhurnal 336(4): 44-49
Selivestrova, T.R.; Trufanova, I.M.; Morozov, S.V.; Isakov, V.A. 2011: Indicators of body composition as prognostic factors of efficiency of antiviral therapy for chronic hepatitis C Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 54-58
Muñoz, A.E. 2007: New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C Acta Gastroenterologica Latinoamericana 37(2): 126-133
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Liu, D.; Wen, X.; Meng, Q. 1998: An observation on antiviral effect of IFN--alpha N1 (Wellferon) in patients with chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 12(2): 125-128
Ono, S.K.; da Silva, L.C.; Carrilho, F.J.; da Fonseca, L.E.; Mendes, L.C.; Madruga, C.L.; Farias, A.d.Q.; Laudanna, A.A. 1996: Clearance of hepatitis C viral RNA in cirrhotic patients with antiviral therapy Revista do Hospital das Clinicas 51(5): 180-183
Jurczyk, K.; Karpińska, E.; Wawrzynowicz-Syczewska, M.; Morańska, I.; Noceń, I.; Chlubek, D.; Boroń-Kaczmarska, A. 2008: State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin Hepato-Gastroenterology 55(82-83): 557-561
Ow, M.M.G.; de Zoysa, J.R.; Gane, E.J. 2014: The impact of oral antiviral therapy on long-term survival of hepatitis B surface antigen-positive patients on haemodialysis New Zealand Medical Journal 127(1396): 34-42
Pereira, Hée.Marina.do.Valle.; Cavalheiro, N.de.Paula.; Tengan, Fátima.Mitiko.; Melo, C.Eduardo.; Mello, E.Sobroza.de.; Barone, Aônio.Alci. 2005: Patients with chronic hepatitis C and normal transaminases Revista do Instituto de Medicina Tropical de Sao Paulo 47(5): 247-251
Chen, J.-L.; Wang, L.; Yan, J.; Zhang, L.; Yu, H.; Fan, X.-L. 2007: Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(3): 273-275
Thiele, D.L.; DuCharme, L.; Cunningham, M.R.; Mimms, L.T.; Cuthbert, J.A.; Lee, W.M.; Combes, B. 1996: Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients American Journal of Gastroenterology 91(2): 300-308
Schalm, S.W.; Brouwer, J.T. 1997: Antiviral therapy of hepatitis C Scandinavian Journal of Gastroenterology. Suppl 223: 46-49
Gu, X.-b.; Yang, X.-j.; Wang, D.; Hua, Z.; Wu, H.-y.; Xu, Y.-q.; Lu, Z.-h. 2009: Relations between ALT level and count of HBV special CTL and non-specific CTL in patients with chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(5): 343-345
Bacq, Y.; Schillio, Y.; Brechot, J.F.; De Muret, A.; Dubois, F.; Metman, E.H. 1993: Decrease of haptoglobin serum level in patients with chronic viral hepatitis C Gastroenterologie Clinique et Biologique 17(5): 364-369